percentage of americans on glp 1 in 8 is now taking a GLP-1 medication. Yet for many patients, the conversation still begins and ends with weight loss. The future GLP-1 therapy lies in comprehensive protocols New weight-loss drugs surge in
Description
Patient consent Written informed consent has been obtained from the patient for publication of the submitted article and accompanying images
A small human study examining the addition of phentermine to liraglutide found no meaningful additional weight loss compared to liraglutide alone
PMID 23953570
/images/2025/03/06/80a97023-8cda-4f9b-9f34-acfd82496b14.png)
The medication alone is not a complete solution for most people
Non-refrigerated medications ship via ground service
